Get our newsletters

$10 Million awards given to 23 PA entities to develop effective COVID-19 vaccines, treatments and therapies

Today, Gov.Tom Wolf announced that 23 awardees will receive $10 million in grant funding through the COVID-19 Vaccines, Treatments and Therapies (CV-VTT) program to support the rapid advancement of vaccines, treatments and therapies by qualified biotechnology entities in response to the COVID-19 pandemic.
Of the 23 projects, $6.8 million was awarded to 12 vaccine projects, nearly $1.2 million was awarded to five therapy projects, nearly $1.6 million was awarded to five treatment projects, and $430,000 was awarded to a project that will support the-build out of physical infrastructure, advancing the development of leading edge innovations in the fight against SARS-CoV-2.
Projects awarded funding include those that will study the use of cancer medications o COVID-19 patients; the development of a research and training space to accelerate the pace of COVID-19 treatment development; the acceleration of vaccine development efforts; and the development of a protective antibody for at-risk individuals, including the elderly, among other innovative and promising new ideas.
The full list of grant recipients can be found here.
The program was made available to Pennsylvania-based entities that demonstrate both a financial need and a well-defined pathway to the accelerated commercialization of a new vaccine, treatment or therapy in direct response to fight against COVID-19.
Funding for the program was appropriated from the Act 2A of 2020, known as the COVID-19 Emergency Supplement to the General Appropriation Act of 2019, to the Pennsylvania Department of Health (DOH), to be administered through a Notice of Subgrant by the Pennsylvania Department of Community and Economic Development’s (DCED) Office of Technology and Innovation.